Globe Life Inc.: Q3 FY2025 earnings call

What management said about Q3 FY2025, from the documents filed with the SEC on 22 October 2025: press release. Guidance figures: 1 new. The quarter’s numbers.

Read the filing

Key takeaways

• Net operating income per share rose 38%: Net income was $4.73 per diluted share against $3.44 a year earlier. Net operating income was $4.81 against $3.49, and net operating income per share increased 38% over the year-ago quarter. Source
• Family Heritage health sales grew 13%: Family Heritage health net sales rose 13% and health premium rose 10%. Its health underwriting margin rose 49% to $50,609 thousand, or 43% of premium, from 32%. Source
• Life and health margins both rose: Life underwriting margin rose 24% to $481,608 thousand, or 57% of premium against 47%. Health underwriting margin rose 25% to $108,374 thousand, or 28% of premium against 25%. Source
• Buybacks totaled $113 million: The company repurchased 840,242 shares at a total cost of $113 million, at an average price of $134.17. The second-quarter release reported 1.9 million shares repurchased for $226 million. Source
• Book value per share rose: Book value per share was $69.52, against $54.65 a year earlier. Excluding AOCI, book value per share was $93.63, against $83.92. Shareholders' equity was $5,689,088 thousand, against $4,638,625 thousand. Source
• 2025 per-share range narrowed: Net operating income per share for 2025 is projected at $14.40 to $14.60, against $14.25 to $14.65 in the second-quarter release. The midpoint is $14.50 in both. Source
• 2026 per-share range first given: Net operating income per share for 2026 is estimated at $14.60 to $15.30. This is the first 2026 range in these documents. Source
• Remeasurement gain of $134.3 million: Updated assumptions produced a $134.3 million pre-tax remeasurement gain, of which $130.9 million was Life and $3.4 million Health. The year-ago quarter had a $46.3 million gain. Source

“These cash flows are not impacted by volatile equity markets.”

Globe Life Inc., press release

Guidance

What changed from last quarter

• New guidance: A 2026 net operating income per share range of $14.60 to $15.30 was given for the first time in these documents. Source

Earnings per share and growth

• Net operating income per share rose 38%: Net income was $4.73 per diluted share against $3.44 a year earlier. Net operating income was $4.81 against $3.49, and net operating income per share increased 38% over the year-ago quarter. Source
• Insurance underwriting income rose 30%: Insurance underwriting income was $503,135 thousand, up 30%, or $6.13 per share, up 39%. Excess investment income was $36,883 thousand, down 7%, or $0.45 per share, flat. Source
• Nine-month returns on equity reported: Net income as an ROE was 21.9% for the nine months ended September 30, 2025, against 22.4% a year earlier. Net operating income as an ROE excluding AOCI was 16.6%, against 15.3%. Source

Life and health by distribution channel

• Family Heritage health sales grew 13%: Family Heritage health net sales rose 13% and health premium rose 10%. Its health underwriting margin rose 49% to $50,609 thousand, or 43% of premium, from 32%. Source
• Direct to Consumer life sales up 13%: Direct to Consumer life net sales rose 13% to $27,176 thousand. Its life underwriting margin rose 29% to $113,744 thousand, or 46% of premium, while its life premium fell 1%. Source
• Liberty National life margin rose 57%: Liberty National life underwriting margin rose 57% to $70,290 thousand, or 72% of premium against 48%. Its life premium rose 5%, and its life net sales were flat at $24,296 thousand. Source
• Life share of margin rose to 82%: Life supplied 82% of insurance underwriting margin and 69% of premium revenue. Health supplied 18% of margin and 31% of premium. The second-quarter release gave 78% and 22% for its quarter. Source
• Liberty National health margin declined: Liberty National health underwriting margin fell 5% to $24,816 thousand, or 52% of premium. United American health underwriting margin rose 15% to $16,098 thousand. Source

“Liquidity at the Parent Company is sufficient to meet additional capital needs of the insurance companies.”

Globe Life Inc., press release

Sales, premiums and agent counts

• Health net sales rose 21%: Net health sales totaled $71,417 thousand against $59,206 thousand, up 21%. United American health net sales rose 58%, while American Income health net sales fell 17%. Source
• Life net sales rose 2%: Life net sales totaled $150,538 thousand against $147,424 thousand, up 2%. American Income and Liberty National were flat, and Direct to Consumer rose 13%. Source
• Total premium rose 5%: Total premium was $1,231,007 thousand, up 5%. Life premium rose 3% to $844,483 thousand, and health premium rose 9% to $386,524 thousand. Source
• Producing agent count rose 9%: The average producing agent count rose 9% at Family Heritage, to 1,553 from 1,429. American Income rose 2% to 12,230, and Liberty National rose 1% to 3,847. Source

Underwriting margins and expenses

• Life and health margins both rose: Life underwriting margin rose 24% to $481,608 thousand, or 57% of premium against 47%. Health underwriting margin rose 25% to $108,374 thousand, or 28% of premium against 25%. Source
• Administrative expense ratio improved: Administrative expenses were $89,767 thousand against $88,465 thousand. The ratio of administrative expenses to premium was 7.3%, compared with 7.5% a year earlier. Source
• Life benefits fell on remeasurement gain: Life policyholder benefits were $381,511 thousand against $454,502 thousand. The total life remeasurement gain in benefits was $149.5 million, against $70.6 million a year earlier. Source
• Amortization and other costs rose: Amortization of deferred acquisition costs was $114,074 thousand against $104,310 thousand. Other operating expense was $111,562 thousand against $104,874 thousand, and interest expense was $36,134 thousand against $31,388 thousand. Source

“Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business.”

Globe Life Inc., press release

Investment income and portfolio

• Excess investment income fell 7%: Net investment income was $286,013 thousand, flat. Required interest on policy liabilities rose about 1.5%, and excess investment income fell 7% to $36,883 thousand, flat at $0.45 per share. Source
• Portfolio yield edged up: The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.26%, against 5.25% a year earlier. 98% of fixed maturities were rated investment grade. The company is not a party to any credit default swaps. Source
• New bond purchases at higher yield: Fixed maturity acquisitions totaled $279,333 thousand at a 6.3% average annual effective yield and A+ average rating. The year-ago quarter had $81,569 thousand at 6.2% and A-. Source
• Other investment purchases declined: Other investment acquisitions totaled $86,780 thousand, against $323,500 thousand a year earlier. The year-ago quarter included $200,000 thousand of company owned life insurance. Source

Share repurchases and book value

• Buybacks totaled $113 million: The company repurchased 840,242 shares at a total cost of $113 million, at an average price of $134.17. The second-quarter release reported 1.9 million shares repurchased for $226 million. Source
• Book value per share rose: Book value per share was $69.52, against $54.65 a year earlier. Excluding AOCI, book value per share was $93.63, against $83.92. Shareholders' equity was $5,689,088 thousand, against $4,638,625 thousand. Source
• Weighted diluted shares declined: Weighted average diluted shares outstanding fell to 82,015 thousand from 88,087 thousand. Nine-month net income per diluted share was $10.77, against $8.93 a year earlier. Source

Guidance for 2025 and 2026

• 2025 per-share range narrowed: Net operating income per share for 2025 is projected at $14.40 to $14.60, against $14.25 to $14.65 in the second-quarter release. The midpoint is $14.50 in both. Source
• 2026 per-share range first given: Net operating income per share for 2026 is estimated at $14.60 to $15.30. This is the first 2026 range in these documents. Source

Remeasurement gain and reconciling items

• Remeasurement gain of $134.3 million: Updated assumptions produced a $134.3 million pre-tax remeasurement gain, of which $130.9 million was Life and $3.4 million Health. The year-ago quarter had a $46.3 million gain. Source
• Realized and legal items reported: Realized losses, net of tax, were $3,939 thousand, or $0.05 per share, against $1,732 thousand. Legal proceedings charges were $2,045 thousand, against $2,630 thousand a year earlier. Source
• Health remeasurement turned to a gain: Health remeasurement was a gain of $8.8 million for the quarter. The year-ago quarter had a total health remeasurement loss of $9.6 million. Source

Figures management reported

Other quarters

• Q2 FY2026 earnings call
• Q1 FY2026 earnings call
• Q4 FY2025 earnings call
• Q2 FY2025 results

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.